Clinical Trials
2
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age
Not Applicable
- Conditions
- Streptococcus PneumoniaVaccine Preventable Disease
- First Posted Date
- 2021-12-01
- Last Posted Date
- 2021-12-01
- Lead Sponsor
- Vabiotech
- Target Recruit Count
- 300
- Registration Number
- NCT05140720
The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks
Not Applicable
Completed
- Conditions
- DiphtheriaTetanusPertussisHepatitis BHaemophilus Influenzae Type B
- First Posted Date
- 2019-04-30
- Last Posted Date
- 2019-05-03
- Lead Sponsor
- Vabiotech
- Target Recruit Count
- 222
- Registration Number
- NCT03931239
- Locations
- 🇻🇳
Hung Yen, Kim Dong, Hung Yen, Vietnam
News
No news found